Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07205900 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 250 to confirmed 267
    • Study sites: 13 to 14
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 12 to 13
    • Start date changed from estimate of Oct 2025 to Dec 2, 2025
    • Secondary endpoint revised
    • Study title shortened, about 3 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Trial Details
NCT Number NCT07205900
Lead Sponsor Hanmi Pharmaceutical Company Limited
Conditions
(from sponsor)		 Obese, Obesity
Related terms Obesity
Enrollment 267 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov